BioCentury
ARTICLE | Company News

TPG Capital, Endo deal

October 26, 2015 7:00 AM UTC

Endo completed its acquisition of generics company Par Holdings Inc. (Woodcliff Lake, N.J.) from investment firm TPG for $7.7 billion. The deal comprised $6.5 billion in cash and 18 million Endo share...